Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cain Brothers is an active U.S.-based investment bank specializing exclusively in the healthcare sector—including life sciences—with deep expertise in mergers & acquisitions advisory services and capital markets solutions for providers/payers as well as medtech/life science companies. Founded in New York City in 1982 and acquired by KeyBanc Capital Markets in August 2017, it operates today as a key division within that group serving clients nationwide. It does not develop drugs or devices itself but plays a major role advising those who do throughout all stages of growth and transaction activity across the health ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cain Brothers.